articl
highlight
issu
aris
patent
law
appli
field
veterinari
medicin
part
applic
patent
law
veterinari
pharmaceut
parallel
applic
human
pharmaceut
outcom
depend
particular
fact
case
area
howev
law
differ
veterinari
product
specif
area
patent
term
restor
safe
harbor
use
discuss
final
section
articl
patent
government
grant
temporari
right
exclud
other
make
use
sell
claim
invent
limit
number
year
polici
matter
grant
patent
sometim
view
quid
pro
quo
wherebi
innov
advanc
full
disclosur
use
invent
exchang
grant
exclus
right
life
patent
innov
possibl
exclus
right
provid
incent
invest
research
develop
public
full
disclosur
invent
publish
patent
document
expand
gener
knowledg
base
lead
innov
subject
matter
amen
patent
protect
area
anim
health
veterinari
medicin
includ
new
activ
ingredi
use
new
process
make
activ
ingredi
regardless
whether
compound
old
new
new
form
formul
dosag
form
old
activ
ingredi
new
use
old
activ
ingredi
eg
new
indic
new
speci
new
patient
subgroup
new
dosag
regimen
new
rout
administr
etc
new
combin
mixtur
old
activ
ingredi
new
vaccin
newli
isol
purifi
substanc
novel
isol
field
genet
engin
microorgan
recombin
nucleic
acid
polypeptid
recombin
vector
transform
cell
line
transgen
anim
eg
knockout
mice
oncogen
mice
etc
monoclon
antibodi
hybridoma
screen
assay
identifi
new
activ
ingredi
assay
measur
anim
trait
efficaci
safeti
drug
administr
anim
method
diagnosi
new
devic
packag
new
method
busi
softwar
andmicrochip
implant
major
requir
obtain
patent
summar
briefli
statutori
subject
matter
subject
matter
sought
patent
must
type
elig
patent
protect
matter
law
applic
patent
statut
jurisdict
see
list
exampl
veterinari
field
us
law
util
invent
must
use
real
world
util
use
must
specif
substanti
credibl
util
requir
usual
issu
veterinari
field
novelti
invent
must
truli
new
exist
beforehand
nonobvi
enough
new
invent
must
also
nonobvi
person
ordinari
skill
art
mani
foreign
jurisdict
correspond
patent
requir
refer
invent
step
see
eg
articl
european
patent
convent
suffici
disclosur
patent
specif
file
us
patent
law
requir
patent
applic
disclos
best
mode
carri
claim
invent
provid
adequ
written
descript
make
use
invent
regard
adequaci
patent
applic
written
descript
make
use
invent
contemporari
case
law
us
highlight
two
signific
test
classic
two
often
refer
enabl
technologicallybas
test
whether
one
ordinari
skill
art
could
make
use
claim
invent
without
undu
experiment
major
test
adequ
disclosur
us
often
refer
written
descript
requir
test
focus
factor
whether
inventor
shown
patent
specif
suffici
word
detail
truli
possess
invent
claim
us
law
pertain
suffici
disclosur
codifi
usc
paragraph
provid
specif
shall
contain
written
descript
invent
manner
process
make
use
full
clear
concis
exact
term
enabl
person
skill
art
pertain
make
use
shall
set
forth
best
mode
contempl
inventor
carri
invent
indic
two
major
aspect
section
criteria
suffici
disclosur
requir
relat
enabl
written
descript
subject
recent
develop
case
law
area
also
present
interest
issu
field
veterinari
medicin
especi
regard
question
broad
claim
one
obtain
limit
number
exampl
speci
disclos
us
standard
evalu
enabl
whether
patent
specif
teach
skill
relev
art
make
use
claim
invent
without
undu
experiment
regard
factor
consid
determin
whether
undu
experiment
requir
refer
usual
made
landmark
case
wand
f
fed
cir
wand
case
patent
claim
issu
relat
immunoassay
method
detect
hepat
b
surfac
antigen
use
highaffin
igm
monoclon
antibodi
issu
whether
undu
experiment
would
requir
produc
monoclon
antibodi
patent
applic
assert
invent
enabl
monoclon
antibodi
need
perform
immunoassay
could
easili
made
readili
avail
start
materi
use
method
well
known
monoclon
antibodi
art
court
agre
note
challeng
applic
content
start
materi
mice
hbsag
antigen
myeloma
cell
avail
public
importantli
futur
case
court
set
forth
follow
eight
factor
consid
determin
whether
undu
experiment
would
need
quantiti
experi
necessari
amount
direct
guidanc
present
presenc
absenc
work
exampl
natur
invent
state
prior
art
rel
skill
art
predict
unpredict
relev
field
breadth
claim
rel
weight
court
give
factor
usual
depend
upon
fact
particular
case
suit
subsequ
wand
case
court
wright
fed
cir
dealt
enabl
issu
concern
vaccin
claim
anim
health
field
order
expand
scope
claim
issu
wright
direct
vaccin
specif
pragu
avian
sarcoma
viru
prasv
chicken
vaccin
avian
rna
virus
vaccin
rna
virus
howev
patent
applic
gave
singl
work
exampl
vaccin
specif
vaccin
prasv
chicken
court
held
narrow
claim
direct
vaccin
specif
chicken
viru
allow
court
also
held
claim
drawn
vaccin
avian
rna
virus
well
claim
direct
rna
virus
enabl
court
cite
exampl
gener
difficulti
develop
rna
viru
vaccin
aid
vaccin
reason
one
work
exampl
simpli
insuffici
given
lack
predict
due
mutat
divers
rna
virus
moreov
court
note
noth
record
establish
immun
respons
caus
antigen
envelop
protein
would
suffici
rise
level
immunoprotect
respons
patent
applic
wright
could
improv
chanc
obtain
broader
claim
scope
work
exampl
especi
multipl
speci
even
broad
claim
rna
virus
might
realist
addit
work
exampl
varieti
avian
speci
could
possibl
led
genu
claim
drawn
vaccin
broader
group
rna
virus
eg
vaccin
genu
rna
virus
poultri
see
potenti
exampl
anim
health
field
might
uniqu
lend
interest
opportun
obtain
genu
claim
within
given
group
anim
area
biotechnolog
life
scienc
one
landmark
case
regard
written
descript
requir
regent
univ
cal
v
eli
lilli
fed
cir
case
univers
present
claim
cover
entir
genu
vertebr
cdna
encod
insulin
addit
claim
drawn
mammalian
insulin
cdna
narrow
claim
drawn
specif
human
insulin
dna
howev
univers
patent
applic
disclos
rat
cdna
along
amino
acid
sequenc
human
insulin
method
isol
human
dna
use
rat
sequenc
rule
univers
claim
fail
meet
written
descript
requir
therefor
unpatent
court
state
descript
rat
insulin
cdna
descript
broad
class
vertebr
mammalian
insulin
cdna
cite
fier
v
revel
fed
cir
court
reiter
belief
claim
cdna
requir
kind
specif
usual
achiev
mean
recit
sequenc
nucleotid
make
dna
rational
lilli
case
subsequ
incorpor
guidelin
us
patent
trademark
offic
synopsi
applic
written
descript
guidelin
guidelin
could
particular
relev
regard
crossspeci
issu
field
veterinari
medicin
indic
exampl
base
lone
speci
rat
cdna
repres
claim
genu
mammalian
cdna
would
suffici
meet
written
descript
requir
differ
result
howev
reach
case
amgen
v
hoechst
fed
cir
technic
subject
matter
involv
host
cell
rather
cdna
case
amgen
claim
broadli
direct
vertebr
host
cell
mammalian
host
cell
amgen
exampl
limit
monkey
cell
chines
hamster
ovari
cell
nevertheless
court
held
sinc
host
cell
differ
cdna
term
readili
convey
distinguish
inform
concern
ident
amgen
disclosur
satisfi
written
descript
test
one
skill
art
could
easili
recogn
ident
member
claim
genu
furthermor
came
enabl
requir
court
reli
primarili
expert
testimoni
rule
amgen
broad
claim
vertebr
mammalian
host
cell
suffici
enabl
disclosur
two
speci
mammalian
cell
turn
antibodi
technolog
patent
applic
case
noell
v
lederman
fed
cir
claim
drawn
human
antibodi
mammalian
antibodi
origin
disclosur
describ
claim
mous
antibodi
court
appli
standard
set
lilli
rule
patent
applic
specif
narrow
disclosur
mous
antigen
suffici
support
patent
claim
gener
scope
coverag
antibodi
especi
come
speci
court
held
antibodi
claim
must
fulli
character
proper
written
descript
note
long
applic
disclos
fulli
character
antigen
either
structur
formula
chemic
name
physic
properti
deposit
antibodi
public
depositori
applic
claim
antibodi
bind
affin
describ
antigen
us
law
pertain
obvious
codifi
usc
provid
pertin
part
patent
may
differ
subject
matter
sought
patent
prior
art
subject
matter
whole
would
obviou
time
invent
made
person
ordinari
skill
case
graham
v
john
deer
us
us
suprem
court
set
follow
three
step
assess
whether
subject
matter
patent
claim
obviou
determin
scope
content
prior
art
ascertain
differ
prior
art
claim
issu
andassess
level
ordinari
skill
pertin
art
beyond
basic
threestep
test
suprem
court
also
note
relev
secondari
consider
follow
could
also
use
commerci
success
invent
long
felt
unsolv
need
present
invent
andth
failur
other
graham
v
deer
remain
semin
case
obvious
throughout
four
decad
sinc
issuanc
recent
year
howev
critic
grew
court
appeal
feder
circuit
main
appeal
court
patent
case
interpret
graham
v
deer
test
way
unfairli
rais
bar
parti
tri
invalid
patent
particular
feder
circuit
court
critic
rigidli
requir
parti
demonstr
specif
teach
suggest
motiv
combin
refer
alleg
obvious
test
often
refer
tsm
test
issu
tsm
test
final
argu
suprem
court
novemb
muchanticip
case
ksr
intern
v
teleflex
ksr
question
suprem
court
whether
claim
invent
obviou
therefor
unpatent
usc
without
proof
teach
suggest
motiv
modifi
combin
prior
art
manner
claim
ksr
accus
infring
argu
claim
invent
patent
suit
combin
known
adjust
ga
pedal
known
electron
throttl
control
mere
repres
obviou
combin
exist
devic
respons
parti
assert
patent
teleflex
argu
feder
circuit
case
law
pertain
obvious
requir
parti
demonstr
specif
teach
suggest
motiv
combin
refer
teach
case
evid
specif
teach
suggest
motiv
combin
known
ga
pedal
known
electron
control
april
suprem
court
issu
decis
revers
feder
circuit
rigid
approach
find
claim
combin
obviou
note
court
free
take
account
infer
creativ
step
person
ordinari
skill
art
would
employ
suprem
court
held
analysi
obvious
need
seek
precis
teach
direct
specif
subject
matter
challeng
claim
reach
decis
suprem
court
point
court
ignor
common
sens
observ
familiar
item
may
obviou
use
beyond
primari
purpos
mani
case
person
ordinari
skill
abl
fit
teach
multipl
patent
togeth
like
piec
puzzl
time
court
cogniz
patent
examin
parti
assert
obvious
claim
invent
allow
use
hindsight
link
two
distant
refer
togeth
without
reason
basi
accordingli
court
caution
assert
obvious
sustain
mere
conclusori
statement
instead
must
articul
reason
ration
underpin
support
legal
conclus
obvious
see
ksr
intern
co
v
teleflex
inc
ct
quot
kahn
f
fed
cir
may
three
day
ksr
decis
deputi
commission
patent
oper
us
patent
trademark
offic
uspto
issu
interim
statement
note
inter
alia
suprem
court
ksr
total
reject
use
teach
suggest
motiv
factor
obvious
analysi
rather
court
recogn
show
teach
suggest
motiv
combin
prior
art
meet
claim
subject
matter
could
provid
help
insight
determin
whether
claim
subject
matter
obviou
court
reject
rigid
applic
teach
suggest
motiv
tsm
test
court
note
analysi
support
reject
usc
made
explicit
import
identifi
reason
would
prompt
person
ordinari
skill
relev
field
combin
prior
art
element
manner
claim
view
last
point
deputi
commission
interim
statement
conclud
formul
reject
usc
base
upon
combin
prior
art
element
remain
necessari
patent
examin
identifi
reason
person
ordinari
skill
art
would
combin
prior
art
element
manner
claim
although
technolog
issu
ksr
case
relat
design
auto
part
suprem
court
rule
issu
obvious
expect
shape
futur
patent
life
scienc
particular
one
anticip
becom
easier
argu
patent
claim
obviou
furthermor
rebut
prima
faci
case
obvious
patent
applic
futur
like
meet
higher
standard
proof
like
need
reli
strong
evid
test
data
tangibl
evid
show
unexpectedli
improv
properti
test
data
tangibl
evid
show
claim
invent
unforese
properti
found
prior
art
argument
evid
prior
art
show
bia
tri
newli
claim
combin
europ
obvious
known
lack
invent
step
european
patent
convent
epc
case
law
undergon
uniqu
evolut
respect
issu
analyz
gener
evalu
invent
step
europ
start
identif
closest
prior
art
technic
problem
solv
follow
analysi
whether
technic
solut
problem
repres
unexpect
nonobvi
advanc
closest
prior
art
combin
either
second
prior
art
refer
common
gener
knowledg
relev
art
thorough
review
european
case
law
invent
step
found
case
law
board
appeal
european
patent
offic
pp
ed
particular
regard
life
scienc
worth
note
case
modifi
plant
cellsmycogen
oj
epo
vaccinesgenentech
triazol
agrevo
oj
epo
interest
interplay
invent
step
requir
articl
epc
suffici
disclosur
requir
articl
epc
particular
case
show
practic
european
patent
offic
socal
problem
solut
approach
evalu
whether
problem
given
case
solv
across
full
scope
claim
limit
patent
proprietor
claim
scope
commensur
proprietor
actual
contribut
art
evalu
obvious
patent
law
interest
situat
could
aris
veterinari
field
one
involv
crossspeci
scenario
situat
therapeut
use
given
activ
ingredi
class
activ
ingredi
alreadi
known
one
anim
speci
new
invent
use
activ
ingredi
member
known
class
activ
ingredi
second
anim
speci
eg
situat
known
use
drug
x
dog
claim
invent
use
drug
x
cat
situat
known
use
specif
class
drug
human
claim
invent
use
particular
member
class
drug
anim
situat
favor
scenario
patent
applic
prior
art
public
teach
least
suggest
actual
bia
use
therapeut
newli
claim
speci
anim
hypothet
exampl
scenario
would
follow
prior
art
show
certain
class
compound
use
success
dog
sever
compound
within
class
previous
shown
work
cat
better
yet
patent
applic
toxic
cat
andth
new
invent
paradox
find
novel
compound
within
known
class
compound
turn
perfectli
safe
effect
cat
type
favor
prior
art
landscap
sometim
refer
among
patent
practition
teach
away
prejudic
art
usual
easiest
argument
make
patent
applic
fortun
enough
favor
prior
art
landscap
backdrop
newli
claim
invent
case
novel
compound
surpris
properti
difficult
situat
prior
art
show
use
compound
class
compound
multipl
speci
anim
new
invent
speci
anim
drug
class
drug
yet
tri
situat
patent
applic
attempt
identifi
reason
might
bia
use
drug
new
speci
support
argument
applic
show
prefer
use
strong
data
claim
invent
yield
surpris
unexpectedli
superior
result
one
ordinari
skill
art
time
would
reason
expect
success
new
anim
speci
exampl
crossspeci
scenario
refer
made
us
patent
us
patent
us
patent
relat
method
vaccin
cow
particular
pathogen
neospora
first
isol
identifi
dog
us
patent
relat
canin
coronaviru
vaccin
employ
felin
enter
coronaviru
case
us
patent
prior
art
show
crossprotect
studi
felin
enter
coronaviru
offer
littl
protect
certain
heterolog
speci
eg
pig
thu
provid
bia
prior
art
crossspeci
efficaci
among
thing
patent
applic
argu
art
develop
vaccin
prevent
canin
corona
viru
infect
dog
unpredict
base
antigen
relationship
coronavirada
virus
interest
issu
potenti
applic
veterinari
medicin
field
concern
question
patent
area
assay
analyz
effect
drug
us
mani
countri
world
well
establish
assay
method
carri
assay
properli
subject
matter
patent
provid
standard
criteria
patent
met
thu
situat
patente
grant
claim
cover
assay
requir
regulatori
agenc
use
connect
administr
given
therapi
question
could
aris
kind
lost
profit
reason
royalti
injunct
relief
patente
could
entitl
receiv
claim
assay
inde
carri
parti
order
compli
regulatori
requir
regard
clinic
test
drug
approv
process
often
valid
except
infring
section
e
us
patent
statut
section
e
provid
safe
harbor
exempt
patent
infring
use
reason
relat
develop
submiss
inform
feder
law
regul
drug
veterinari
biolog
product
special
exempt
given
fairli
broad
interpret
recent
case
law
howev
parti
commerci
therapeut
parti
longer
use
section
e
exempt
defens
also
would
defens
simpli
say
clinician
veterinarian
infring
compani
suppli
therapeut
product
compani
sell
product
commerci
could
accus
induc
infring
usc
b
contribut
infring
usc
c
although
beyond
scope
articl
specul
might
play
court
remedi
might
might
avail
court
case
may
interest
analysi
see
eg
hybritech
inc
v
abbott
laboratori
f
fed
cir
defend
infring
cancer
hepat
test
kit
includ
preliminari
injunct
order
defend
sinc
patente
offer
kit
supplier
time
moreov
us
suprem
court
recent
issu
landmark
decis
remedi
patent
infring
case
rule
longer
gener
rule
patent
case
court
almost
alway
issu
perman
injunct
infring
specif
ebay
inc
v
mercexchang
llc
us
ct
suprem
court
held
patent
case
like
type
case
perman
injunct
issu
remedi
appropri
light
equit
principl
mean
remedi
must
assess
wellestablish
fourfactor
test
use
case
wherebi
plaintiffpatente
seek
perman
injunct
requir
show
patente
suffer
irrepar
harm
standard
legal
remedi
monetari
damag
inadequ
compens
injuri
perman
injunct
warrant
view
balanc
hardship
patente
infring
anda
perman
injunct
would
public
interest
thu
particular
regard
fourth
factor
accus
infring
argu
injunct
relief
public
interest
eg
accus
product
lifesav
cure
avail
sourc
greater
chanc
new
case
law
judg
might
refus
order
injunct
despit
infring
valid
patent
within
field
veterinari
pharmaceut
issu
uniqu
twist
drug
approv
use
foodproduc
anim
residu
limit
withdraw
time
establish
ensur
safeti
animalderiv
food
eg
egg
milk
meat
human
consumpt
compon
applic
establish
human
food
safeti
must
contain
analyt
method
properli
valid
perform
characterist
method
integr
establish
withdraw
time
ie
time
last
dose
animalderiv
food
product
consid
safe
human
consumpt
interestingli
although
analyt
method
would
consid
part
product
dossier
analyt
method
becom
integr
compon
drug
monitor
program
must
method
use
laboratori
involv
monitor
food
viol
residu
furthermor
legal
proceed
us
associ
prosecut
parti
market
drugtaint
food
data
gener
use
fdaapprov
analyt
method
reli
upon
support
prosecut
origin
legisl
pass
compromis
pioneer
pharmaceut
compani
gener
compani
pioneer
compani
concern
spend
enorm
sum
money
develop
new
drug
yet
durat
time
drug
discoveri
commerci
often
erod
valuabl
patent
term
gener
compani
hand
argu
could
get
market
year
patent
expir
famou
case
roch
v
bolar
fed
cir
held
test
develop
pursuit
regulatori
approv
constitut
infring
even
though
gener
compani
will
wait
patent
expir
commerci
product
develop
provid
foundat
legisl
wherebi
gener
compani
given
benefit
earlier
entri
possibl
exchang
pioneer
compani
abl
retriev
limit
extent
lost
year
valuabl
patent
life
unus
due
regulatori
approv
process
legal
framework
part
extend
field
veterinari
medicin
enact
gener
anim
drug
patent
term
restor
act
gadptr
like
human
side
gadptr
gave
gener
compani
benefit
earlier
entri
possibl
exchang
pioneer
compani
abl
retriev
lost
year
valuabl
patent
life
unus
due
regulatori
approv
process
howev
signific
differ
statutori
provis
human
side
statutori
provis
veterinari
side
discuss
patent
term
restor
statut
make
clear
patent
extend
gener
first
approv
use
howev
would
present
potenti
dilemma
anim
health
compani
seek
regulatori
approv
companion
anim
anim
case
compani
obtain
first
approv
companion
anim
indic
much
lucr
indic
foodproduc
anim
still
pend
eg
compani
new
antibiot
approv
dog
approv
cow
remov
potenti
dilemma
uniqu
provis
patent
term
restor
statut
provid
patente
anim
health
area
import
option
actual
defer
onetim
opportun
patent
term
extens
approv
foodproduc
anim
indic
come
repres
unusu
statutori
except
gener
rule
patent
extend
first
approv
except
exist
human
therapeut
unlik
rel
broader
opportun
patent
term
restor
case
human
therapeut
law
anim
health
area
expressli
exclud
patente
obtain
patent
term
restor
genet
engin
anim
drug
ie
drug
primarili
manufactur
use
recombin
dna
recombin
rna
hybridoma
technolog
process
involv
sitespecif
genet
manipul
techniqu
exclus
case
human
therapeut
safe
harbor
exempt
patent
infring
provid
usc
e
use
reason
relat
develop
submiss
inform
feder
law
regul
drug
veterinari
biolog
product
appli
human
anim
drug
howev
unlik
human
drug
anim
drug
veterinari
biolog
expressli
exclud
safe
harbor
primarili
manufactur
use
recombin
dna
recombin
rna
hybridoma
technolog
process
involv
sitespecif
genet
manipul
techniqu
question
sometim
aris
whether
second
patent
term
restor
possibl
anim
health
approv
activ
ingredi
alreadi
extend
human
therapeut
product
gener
patent
term
restor
statut
contain
strong
prohibit
obtain
second
patent
term
restor
activ
ingredi
howev
one
read
care
statutori
prohibit
possibl
follow
special
scenario
seen
assum
compani
two
patent
patent
cover
use
compound
x
human
indic
approv
section
feder
food
drug
cosmet
act
fdca
patent
b
cover
use
compound
x
anim
indic
approv
section
fdca
particular
situat
assum
condit
met
compani
obtain
one
patent
human
indic
plu
addit
patent
veterinari
indic
key
scenario
cours
assumpt
patent
extend
scope
cover
veterinari
use
patent
b
extend
scope
cover
human
use
us
human
drug
meet
certain
specifi
requir
involv
addit
test
pediatr
use
qualifi
extra
six
month
exclus
addit
applic
exclus
period
correspond
pediatr
exclus
anim
drug
us
human
drug
meet
requisit
condit
eg
rare
diseas
affect
fewer
patient
obtain
socal
orphan
drug
design
orphan
drug
act
wherebi
holder
entitl
sever
specifi
benefit
possibl
tax
credit
seven
year
exclus
respect
specifi
orphan
indic
orphan
drug
act
extend
anim
drug
howev
anim
drug
meet
certain
criteria
possibl
obtain
socal
minor
useminor
speci
mum
design
qualifi
minor
speci
eg
goat
sheep
fish
etc
uncommon
minor
use
major
anim
group
cattl
cat
dog
swine
poultri
etc
mum
design
also
provid
seven
year
market
exclus
indic
provid
basi
patent
extens
tax
credit
australian
law
provid
special
springboard
safe
harbor
exempt
patent
infring
wherebi
clinic
test
human
pharmaceut
product
unlicens
parti
term
relev
purpos
obtain
regulatori
approv
gener
version
patent
product
howev
unlik
provis
clinic
trial
us
europ
veterinari
product
enjoy
safe
harbor
rel
similar
enjoy
human
product
particular
springboard
safe
harbor
australia
appli
pharmaceut
veterinari
field
thu
repres
stark
exampl
law
veterinari
pharmaceut
differ
law
human
pharmaceut
author
continu
search
exampl
provis
nation
patent
law
might
uniqu
applic
case
veterinari
medicin
would
welcom
learn
exampl
reader
may
encount
reader
may
also
want
take
closer
look
area
law
human
veterinari
field
diverg
consid
whether
diverg
justifi
case
